Panbela Therapeutics Valeur d'entreprise
Quel est le Valeur d'entreprise de Panbela Therapeutics?
Le Valeur d'entreprise de Panbela Therapeutics Inc. est $9.68M
Quelle est la définition de Valeur d'entreprise?
La valeur d'entreprise est une mesure de la valeur marchande totale d'une entreprise. Il correspond à la capitalisation boursière avec la dette, les intérêts minoritaires et les actions privilégiées moins la trésorerie et les équivalents de trésorerie totaux.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Valeur d'entreprise des entreprises dans Health Care secteur sur NASDAQ par rapport à Panbela Therapeutics
Que fait Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Entreprises avec valeur d'entreprise similaire à Panbela Therapeutics
- Makers Laboratories a Valeur d'entreprise de $9.66M
- Mohit Industries a Valeur d'entreprise de $9.67M
- Peppermint Innovation a Valeur d'entreprise de $9.67M
- Invigor a Valeur d'entreprise de $9.67M
- Curative Biosciences a Valeur d'entreprise de $9.68M
- Surefire Resources NL a Valeur d'entreprise de $9.68M
- Panbela Therapeutics a Valeur d'entreprise de $9.68M
- Oakdale Resources a Valeur d'entreprise de $9.69M
- Viva Gold a Valeur d'entreprise de $9.69M
- Edensoft a Valeur d'entreprise de $9.69M
- InnovaDerma Plc a Valeur d'entreprise de $9.69M
- General Assembly a Valeur d'entreprise de $9.70M
- Redbank Copper a Valeur d'entreprise de $9.71M